Thomas Patrick Kelly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report) was upgraded by equities researchers at Jonestrading from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, Benzinga reports. A number of other equities analysts have also issued reports on DCPH. Stifel Nicolaus upgraded shares of Deciphera Pharmaceuticals from a “hold” rating […]

Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.58) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.61) by $0.03, MarketWatch Earnings reports. Deciphera Pharmaceuticals had a negative return on equity of 48.99% and a negative net margin of 127.92%. The firm […]